---
trial_id: 933
discovery_date: 2022-06-13 18:54:30.841003
date: 2022-06-13 18:54:30.841003
title: "An Open-label, Multi-center Rollover Protocol for Patients Who Have Participated in a Novartis-sponsored Ribociclib (LEE011) Study and Are Continuing to Benefit From Ribociclib as Single Agent or in Combination With Other Investigational Treatments"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct02934568'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
